Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2

Author:

Owen Dwight H.1ORCID,Singh Navneet2ORCID,Ismaila Nofisat3ORCID,Blanchard Elizabeth4,Celano Paul5,Florez Narjust6ORCID,Jain Dharamvir7,Leighl Natasha B.8ORCID,Mamdani Hirva9ORCID,Masters Gregory10ORCID,Moffitt Pamela R.11,Naidoo Jarushka12ORCID,Phillips Tanyanika13,Riely Gregory J.14ORCID,Robinson Andrew G.15ORCID,Schenk Erin16ORCID,Schneider Bryan J.17,Sequist Lecia18ORCID,Spigel David R.19ORCID,Jaiyesimi Ishmael A.20

Affiliation:

1. Ohio State University, Columbus, OH

2. Postgraduate Institute of Medical Education and Research, Chandigarh, India

3. American Society of Clinical Oncology, Alexandria, VA

4. Southcoast Centers for Cancer Care, New Bedford, MA

5. The Cancer Center at GBMC, Townson, MD

6. Dana-Farber Cancer Institute, Boston, MA

7. Houston Methodist Cancer Center, Houston, TX

8. Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada

9. Karmanos Cancer Institute/Wayne State University, Detroit, MI

10. Helen F. Graham Cancer Center and Research Institute, Newark, DE

11. Alliance for Clinical Trials in Cancer, Galva, IA

12. Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD

13. City of Hope, Duarte, CA

14. Memorial Sloan Kettering Cancer Center, New York, NY

15. Kingston General Hospital, Queen's University, Kingston, Ontario, Canada

16. University of Colorado Anschutz Medical Center, Aurora, CO

17. University of Michigan Health System, Ann Arbor, MI

18. Massachusetts General Hospital, Boston, MA

19. Sarah Cannon Research Institute, Nashville, TN

20. Beaumont Health Royal Oak and Oakland University William Beaumont School of Medicine, Royal Oak, MI

Abstract

Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual . ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines . Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating provider and do not account for individual variation among patients. See Appendix 1 (online only) for disclaimers and other important information. Updates are published regularly and can be found at https://ascopubs.org/nsclc-da-living-guideline .

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3